1. La Du, N.B., Structural and functional diversity of paraoxonases, Nat. Med., 1996, vol. 2, pp. 1186–1187.
2. Davies, H.G., Richter, R.J., Keifer, M., Broomfield, C.A., Sowalla, J., and Furlong, C.E., The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin, Nat. Genet., 1996, vol. 14, pp. 334–226.
3. Ortigoza-Ferado, J., Richter, R.J., Hornung, S.K., Motulsky, A.G., and Furlong, C.E., Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin, Am. J. Hum. Genet., 1984, vol. 36, pp. 295–305.
4. Adkins, S., Gan, K.N., Mody, M., and La Du, B.N., Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes, Am. J. Hum. Genet., 1993, vol. 52, pp. 598–608.
5. Mazur, A., An enzyme in animal tissues capable of hydrolysing the phosphorus-fluorine bond of alkyl fluorophosphates, J. Biol. Chem., 1946, vol. 164, pp. 271–289.